Another failure heaps more pressure on Novartis
It was already obvious that Novartis’s pipeline needed bolstering, and the group now has the firepower to do so. The situation has become even more urgent today, though, with the failure of a big pipeline hope, ligelizumab.To get more latest news on novartis, you can visit shine news official website.
It is probably a coincidence that this morning the company also announced a deal...